The role of developing group 2 innate lymphoid cell perivascular niches in early life lung immunity
The role of developing group 2 innate lymphoid cell perivascular niches in early life lung immunity
批准号:
396369
负责人:
Steer Catherine
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-11-01 至 2020-11-01
中文摘要
过敏性哮喘是儿童中主要的慢性疾病,其特征是反复发作的呼吸短促、喘息,在某些情况下还会出现灾难性的呼吸衰竭。虽然药物可以治疗哮喘症状,但它仍然是一种无法治愈的疾病
英文摘要
Allergic asthma is the leading chronic disease in children, defined by recurrent episodes of shortness of breath, wheezing, and in some cases catastrophic respiratory failure. Although medications can treat asthma symptoms, it remains an incurable and deb
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of adult type 2 immunity by neonatal ILC2s
-
批准号:347921
-
项目类别:Studentship Programs
-
资助金额:$7.65万
-
财政年份:2015
-
负责人:Steer Catherine
-
依托单位:
Initiation of allergic responses in lung
-
批准号:312020
-
项目类别:Studentship Programs
-
资助金额:$1.27万
-
财政年份:2013
-
负责人:Steer Catherine
-
依托单位:
海外基金